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A B S T R A C T
Acute, subchronic and chronic effects of the P-9801091 plant mixture extract at a dose of 20 mg/kg body mass were as-
sessed in serum of healthy CBA/HZg mice at 24 hours, 7 days, 3 months and 6 months of treatment (experimental group),
and compared with the values obtained in the control group of untreated healthy CBA/HZg mice. The P-9801091 plant
mixture extract is an antihyperglycemic preparation containing Myrtilli folium (Vaccinium myrtillus L.), Taraxaci radix
(Taraxacum officinale Web.), Cichorii radix (Cichorium intybus L.), Juniperi fructus (Juniperus communis L.), Centa-
urii herba (Centaurium umbellatum Gilib.), Phaseoli fructus sine semine (Phaseolus vulgaris L.), Millefolii herba (Ach-
illea millefolium L.), Mori folium (Morus nigra L.), Valerianae radix (Valeriana officinalis L.) and Urticae herba et radix
(Urtica dioica L). Toxic effect of the P-9801091 plant mixture extract was assessed by the following biochemical parame-
ters: urea, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and cholesterol. Also, histo-
pathological examination of the kidneys, liver, spleen, pancreas, testes and lungs was performed. Results of biochemical
testing performed at specified time points generally showed no statistically significant differences from control values,
with the only exception of the catalytic concentration of AST in the experimental group measured on day 7, which was
significantly increased as compared with the control group (p<0.05). Pathohistological examination including charac-
teristic organ and tissue structure, and parenchyma relationship to the adjacent blood vessels and connective tissue in
the examined organs revealed no major pathologic changes.
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Introduction
Type 2 diabetes mellitus is the most common form of
diabetes with specific diagnostic and therapeutic implica-
tions. Normoglycemia is necessary to achieve for the pre-
vention of late diabetes complications1.
Several medicinal plants and their products have
been used to control diabetes in the traditional medicine
worldwide2. According to literature data, hypoglycemic
effect has to date been scientifically assessed in 295
plants used in traditional medicine, 238 (81%) of them
yielding positive results. Many studies investigated the
hypoglycemic properties of medicinal plants3–5. Such a
high percentage of hypoglycemically active plants points
to the great variety of active principles and mechanisms
of action, not all of which may prove therapeutically use-
ful6.
The aim of the present study was to assess acute,
subchronic and chronic toxicity of the P–9801091 plant
mixture extract containing Myrtilli folium (Vaccinium
myrtillus L.), Taraxaci radix (Taraxacum officinale Web.),
Cichorii radix (Cichorium intybus L.), Juniperi fructus
(Juniperus communis L.), Centaurii herba (Centaurium
umbellatum Gilib.), Phaseoli fructus sine semine (Pha-
seolus vulgaris L.), Millefolii herba (Achillea millefolium
L.), Mori folium (Morus nigra L.), Valerianae radix (Vale-
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riana officinalis L.) and Urticae herba et radix (Urtica
dioica L). The antihyperglycemic and antioxidative ef-
fects of the preparation, available on the Croatian mar-
ket, have been previously described7,8. In order to assess
the acute, subchronic and chronic toxic effects of a dried
standardized extract of P-9801091, biochemical and his-
tologic studies were performed in healthy CBA/H Zg mice
over a 6-month period. Similar toxicological studies of
Momordica charantia L. was performed from author El
Batran et. al. 9.The evaluation our study included deter-
mination of serum urea, creatinine, cholesterol, and cat-
alytic concentrations of aspartate aminotransferase (AST)
and alanine aminotransferase (ALT), and histology of the
kidneys, liver, spleen, pancreas, testes and lungs.
Material and Methods
Plant material
In the P-9801091 plant mixture extract, different
plants are present in the following proportion: Centaurii
herba 12.3 % (m/m), Cichorii radix 17.7 % (m/m), Juni-
peri fructus 6.2 % (m/m) Millefolii herba 3.5% (m/m),
Myrtilli folium 6.6 % (m/m), Phaseoli fructus sine semine
14% (m/m), Taraxaci radix 9.7 % (m/m), Urticae herba
7.4 % (m/m), Urticae radix 7.0 % (m/m), Valerianae radix
7.8 % (m/m), and Mori folium 7.4 % (m/m). Species were
identified at the Ru|er Bo{kovi} Institute, Department
of Molecular Medicine, Zagreb, by testing of the external
matter of plants10.
Dry plant material of the P-9801091 preparation was
extracted with 60% ethanol. After 28 days, the macerate
was filtered and ethanol was evaporated on a rotatory
evaporator at a temperature of 45 °C, and lyophilized.
Animals
Fourty-eight male CBA/HZg mice devided in two
groups (control and experimental), three-month-old, body
mass 27–36 g, were used in the study. The mice were bred
at the Laboratory of Molecular Medicine, Ru|er Bo{kovi}
Institute, Zagreb. The mice were cultivated in the Ani-
mal department of the Laboratory of Molecular Medi-
cine. This Laboratory has a certificate of ethical commit-
tee from Institute Ru|er Bo{kovi} with signature and
stamp. During the study, animals were kept at 12-h
light/dark cycle at a temperature of 22–24 °C and fed
standardized laboratory chow (Pliva, Zagreb) with the
addition of lyophilized P-9801091 plant mixture extract
at a dose of 20 mg/kg b.m./day (experimental group) or
standardized laboratory chow (Pliva, Zagreb) without
the addition of P-9801091 plant mixture extract (control
group).
For biochemical analysis, animals were sacrificed hu-
manly in ether narcosis at 24 h, 7 days, 3 months and 6
months (each group consisted of six mice), and for his-
tologic analysis at 6 months of treatment.
Blood samples and serum chemistry
The animals were bled to death from orbital plexus
under light ether anesthesia. Samples of approximately
0.1 mL (13–15 drops) were collected individually into
plastic vials (Microtainer Brand Tube 0.5m, Becton Dick-
inson Cat No. 365973). Serum urea, creatinine, AST,
ALT, and total cholesterol were determined on an Olym-
pus AU-600 autoanalyzer. Urea was measured by ure-
ase-UV method11, creatinine by Jaffe kinetic method12,
AST and ALT by enzymatic kinetic method of Boeh-
ringer Mannheim 13.The reading was done at 340 nm at
30C14. Results were expressed in U/L. Total cholesterol
was determined by enzymatic method15.
Histologic analysis
For histologic evaluation, six mice from each group
were chosen. The tissues examined included the kidneys,
liver, spleen, pancreas and testes. The material obtained
was fixed in 4% formalin solution. For preparation of
paraffin sections, samples were stained with hemato-
xylin and eosin. Thus, permanent histologic slides for mi-
croscopy were obtained.
Statistical analysis
The results are expressed as arithmetic mean and
standard error of the mean. Non-parametric tests, Krus-
kal-Wallis analysis of variance, and Mann-Whitney com-
parison of two independent samples were used for statis-
tical analysis. The level of significance was set at p<0.05
and p<0.01.
Results
Body mass of the mice
In each individual mouse, body mass was determined
once a week for 91 days, by weighing on a SAC 62 1,200
0.1 g Scaltec electric balance. Significant body mass dif-
ferences between the control and experimental animals
were recorded on days 7, 14 and 21 of the study (p<0.01)
(Figure 1).
























Fig. 1. Effect of P-9801091 plant mixture extract on body weight
over a 90-day period. - - - - control CBA/H Zg mice, - - - -
CBA/H Zg mice treated with P-9801091 plant mixture extract at
a dose of 20 mg/kg b.m. *p0.01 compared with control (meant 
SEM; n=10).
Biochemical analysis
Serum concentrations of urea, creatinine, catalytic
concentration of AST, ALT and cholesterol in the experi-
mental and control mice are shown in Table 1.
Urea and creatinine were determined as parameters
of the renal function16,17. During the study period, serum
concentrations of urea and creatinine underwent no sta-
tistically significant changes either within or between
the experimental and control group of animals. In the
control group, no significant changes were recorded for
the catalytic concentration of AST, however, in the exper-
imental group of mice a significant increase in the serum
catalytic concentration of AST was observed on day 7 as
compared to the values recorded at 24 h of treatment
(p<0.05). Comparison of the catalytic concentration of
AST between the control and experimental group of ani-
mals on day 7 revealed a statistically significant increase
in the experimental group (p<0.05). The catalytic con-
centration of ALT and the concentration of cholesterol
showed no significant changes during the study period in
either group of animals (Table 1).
Histologic analysis
Histologic analysis was performed on the kidneys,
liver, spleen, pancreas, testes and lungs (Figure 2.).The
weight of these organs was determined. No changes were
recorded in the weight of the spleen, kidneys, testicles
and liver of either experimental or control group animals
(Table 2). None of the organ sections revealed any histo-
logic or macroscopic alterations.
Discussion
Although numerous plants with a hypoglycemic effect
have been described in the literature18–21, there are oth-
ers reporting on the toxicity of some plant extracts22,23.
Study of Stickel et. al. 200524, summarizes the current
evidence on the potential hepatotoxicity from herbal
drugs, and outlines the problems that need to be ad-
dressed to correctly assess their risk-benefit ratio. In this
study are described that certain herbals have been iden-
tified as a cause of acute and chronic hepatitis, cho-
lestasis, drug-induced autoimmunity, vascular leasions
and even hepatic failure and cirrhosis. Conclusion were
that only rigorous pharmacological testing of herbals can
prove their safety and efficacy.Therefore, the P-9801091
plant mixture extract was given to healthy male CBA/HZg
mice in a daily dose of 20 mg/kg b.m. to assess its acute,
subchronic and chronic toxicity by analysis of relevant
biochemical parameters and organ histology. AST and
ALT are hepatospecific enzymes25. An increase in the en-
zymatic activity of AST and ALT in serum is known to di-
rectly reflect cell rupture26, thus these enzymes are fre-
quently used in the evaluation of liver function27,28.
AST is an enzyme that is present in a high concentra-
tion in the cytoplasm and mitochondria of the liver, and
in lower concentrations in the heart, skeletal muscle,
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TABLE 1
SERUM CONCENTRATIONS OF UREA, CREATININE, AST, ALT AND CHOLESTEROL IN HEALTHY CBA/HZg MICE



















































A – control group: untreated, healthy CBA/HZg mice, B – experimental group, healthy CBA/HZg mice daily treated with the P-9801091
plant mixture at a dose of 20 mg/kg b.m., * p < 0.05 B vs. A, each group containing of six animals
TABLE 2
STANDARDIZED ORGAN WEIGHT (ORGAN WEIGHT/BODY WEIGHT) IN CBA/HZg MICE, CONTROL AND TRATED
WITH P-9801091 PLANT MIXTURE EXTRACT AT A DOSE OF 20 mg/kg b.m.
CBA/H Zg mice Spleen Kidneys Gonads Liver
Control 0.2802 0.6325 0.1933 3.5023
(0.0231) (0.0424) (0.0213) (0.2132)
Treated with 0.3089 0.7196 0.2410 3.7997
P-9801091 (0.0272) (0.0592) (0.0431) (0.3422)
Mean (SEM); n=6; *p<0.01
kidneys and brain25. This enzyme showed significantly
higher values in the experimental group (p<0.05) com-
pared with control animals on day 7 (Table 1), pointing to
the possible initial toxic lesion of the liver. However, this
effect must have subsequently disappeared, since the cat-
alytic concentration of AST in the experimental group
did not differ significantly from the catalytic concentra-
tion found in the control group at 3 and 6 months of treat-
ment. There were no significant changes in the catalytic
concentration of ALT during the study period either.
Serum urea and creatinine are determined as renal le-
sion parameters16,17. As the P-9801091 plant mixture ex-
tract is administered per os and is composed of various
plants, some metabolic components are likely to be elimi-
nated in the urine. Therefore we embarked upon the
study of renal lesion markers. Throughout the experi-
ment, there were no significant differences in the urea
and creatinine concentrations between the experimental
and control group of animals. As the lipid (including cho-
lesterol) metabolism is frequently impaired in diabetes
mellitus,29 we considered it necessary to assess the effect
of P-9801091 plant mixture extract on the blood choles-
terol level. No significant differences in the cholesterol
concentration were recorded between the experimental
and control groups of mice throughout the 6-month ex-
periment (Table 1). During the first 21 days of the study,
body mass was significantly lower in the experimental
group than in the control group of mice (p<0.01), how-
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Fig. 2. Histologic section of (A) kidney, (B) liver, (C) spleen (D) pancreas, (E) testicles, and (F) lung from mice treated with
P-9801091 plant mixture extract for 6 months (20 mg/kg b.m.) (hematoxilin – eosin, x40).
ever, no change in the weight curve was recorded from
day 21 through day 91 of the experiment.
Histologic analysis of the kidneys, liver, spleen, pan-
creas, testes and lungs from the experimental group mice
showed no major pathologic alterations (Figure 2).
It can be concluded that plant mixture extract P-9801091
given to healthy male CBA/HZg mice in a daily dose of 20
mg/kg b.m. during 6 mounts did not toxic effect on the
liver, kidney, spleen, pancreas, testes and lungs.
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TOKSIKOLO[KA PROCJENA BILJNOG EKSTRAKTA P-9801091 NAKON KRONI^NE PRIMJENE
NA CBA/HZg MI[EVIMA-BIOKEMIJSKA I HISTOLO[KA STUDIJA
S A @ E T A K
Akutni, kroni~ni i subkroni~ni u~inak biljnog ekstrakta P-9801091 u dozi od 20 mg/kg tjelesne mase ispitan je na
serumu zdravih CBA/HZg mi{eva nakon 24 sata, 7 dana, 3 mjeseca i 6 mjeseci od po~etka tretmana (pokusna skupina) i
uspore|en s dobivenim vrijednostima u kontrolnoj skupini koju su ~inili netretirani, zdravi CBA/HZg mi{evi. Biljni
ekstrakt P-9801091 je antihiperglikemijski preparat koji sadr`i: Myrtilli folium (Vaccinium myrtillus L.), Taraxaci ra-
dix (Taraxacum officinale Web.), Cichorii radix (Cichorium intybus L.), Juniperi fructus (Juniperus communis L.),
Centaurii herba (Centaurium umbellatum Gilib.), Phaseoli fructus sine semine (Phaseolus vulgaris L.), Millefolii herba
(Achillea millefolium L.), Mori folium (Morus nigra L.), Valerianae radix (Valeriana officinalis L.) and Urticae herba et
radix (Urtica dioica L). Toksi~ni u~inak biljnog preparata P-9801091 procijenjen je pra}enjem slijede}ih biokemijskih
parametara: uree, kreatinina, aspartat aminotransferaze (AST), alanin aminotransferaze (ALT) i kolesterola. Tako|er
je provedeno i histopatolo{ko ispitivanje bubrega, jetre, slezene, gu{tera~e, testisa i plu}a. Rezultati biokemijskih ana-
liza pokusne skupine u navedenom vremenu pokazuju nepostojanje statisti~ki zna~ajnih razlika u odnosu na kontrolnu
skupinu zdravih, netretiranih CBA/HZg mi{eva, s iznimkom kataliti~ke koncentracije AST u pokusnoj skupini mjereno
sedmog dana (p < 0.05). Patohistolo{ko ispitivanje, koje je uklju~ilo ispitivanje strukture karakteristi~nih organa tako-
|er ne pokazuje patolo{ke promjene u odnosu na zdravu, netretiranu skupinu.
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